Chapter/Section Purchase

1 Study Coverage
1.1 BRAF Kinase Inhibitors Product Introduction
1.2 Market by Type
1.2.1 Global BRAF Kinase Inhibitors Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Dabrafenib
1.2.3 Sorafenib
1.2.4 Vemurafenib
1.2.5 Encorafenib
1.3 Market by Application
1.3.1 Global BRAF Kinase Inhibitors Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Medical Research Institute
1.3.4 Clinic
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global BRAF Kinase Inhibitors Sales Estimates and Forecasts 2017-2028
2.2 Global BRAF Kinase Inhibitors Revenue Estimates and Forecasts 2017-2028
2.3 Global BRAF Kinase Inhibitors Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global BRAF Kinase Inhibitors Sales by Region
2.4.1 Global BRAF Kinase Inhibitors Sales by Region (2017-2022)
2.4.2 Global Sales BRAF Kinase Inhibitors by Region (2023-2028)
2.5 Global BRAF Kinase Inhibitors Revenue by Region
2.5.1 Global BRAF Kinase Inhibitors Revenue by Region (2017-2022)
2.5.2 Global BRAF Kinase Inhibitors Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global BRAF Kinase Inhibitors Sales by Manufacturers
3.1.1 Global Top BRAF Kinase Inhibitors Manufacturers by Sales (2017-2022)
3.1.2 Global BRAF Kinase Inhibitors Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of BRAF Kinase Inhibitors in 2021
3.2 Global BRAF Kinase Inhibitors Revenue by Manufacturers
3.2.1 Global BRAF Kinase Inhibitors Revenue by Manufacturers (2017-2022)
3.2.2 Global BRAF Kinase Inhibitors Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by BRAF Kinase Inhibitors Revenue in 2021
3.3 Global BRAF Kinase Inhibitors Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global BRAF Kinase Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global BRAF Kinase Inhibitors Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global BRAF Kinase Inhibitors Sales by Type
4.1.1 Global BRAF Kinase Inhibitors Historical Sales by Type (2017-2022)
4.1.2 Global BRAF Kinase Inhibitors Forecasted Sales by Type (2023-2028)
4.1.3 Global BRAF Kinase Inhibitors Sales Market Share by Type (2017-2028)
4.2 Global BRAF Kinase Inhibitors Revenue by Type
4.2.1 Global BRAF Kinase Inhibitors Historical Revenue by Type (2017-2022)
4.2.2 Global BRAF Kinase Inhibitors Forecasted Revenue by Type (2023-2028)
4.2.3 Global BRAF Kinase Inhibitors Revenue Market Share by Type (2017-2028)
4.3 Global BRAF Kinase Inhibitors Price by Type
4.3.1 Global BRAF Kinase Inhibitors Price by Type (2017-2022)
4.3.2 Global BRAF Kinase Inhibitors Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global BRAF Kinase Inhibitors Sales by Application
5.1.1 Global BRAF Kinase Inhibitors Historical Sales by Application (2017-2022)
5.1.2 Global BRAF Kinase Inhibitors Forecasted Sales by Application (2023-2028)
5.1.3 Global BRAF Kinase Inhibitors Sales Market Share by Application (2017-2028)
5.2 Global BRAF Kinase Inhibitors Revenue by Application
5.2.1 Global BRAF Kinase Inhibitors Historical Revenue by Application (2017-2022)
5.2.2 Global BRAF Kinase Inhibitors Forecasted Revenue by Application (2023-2028)
5.2.3 Global BRAF Kinase Inhibitors Revenue Market Share by Application (2017-2028)
5.3 Global BRAF Kinase Inhibitors Price by Application
5.3.1 Global BRAF Kinase Inhibitors Price by Application (2017-2022)
5.3.2 Global BRAF Kinase Inhibitors Price Forecast by Application (2023-2028)
6 North America
6.1 North America BRAF Kinase Inhibitors Market Size by Type
6.1.1 North America BRAF Kinase Inhibitors Sales by Type (2017-2028)
6.1.2 North America BRAF Kinase Inhibitors Revenue by Type (2017-2028)
6.2 North America BRAF Kinase Inhibitors Market Size by Application
6.2.1 North America BRAF Kinase Inhibitors Sales by Application (2017-2028)
6.2.2 North America BRAF Kinase Inhibitors Revenue by Application (2017-2028)
6.3 North America BRAF Kinase Inhibitors Market Size by Country
6.3.1 North America BRAF Kinase Inhibitors Sales by Country (2017-2028)
6.3.2 North America BRAF Kinase Inhibitors Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe BRAF Kinase Inhibitors Market Size by Type
7.1.1 Europe BRAF Kinase Inhibitors Sales by Type (2017-2028)
7.1.2 Europe BRAF Kinase Inhibitors Revenue by Type (2017-2028)
7.2 Europe BRAF Kinase Inhibitors Market Size by Application
7.2.1 Europe BRAF Kinase Inhibitors Sales by Application (2017-2028)
7.2.2 Europe BRAF Kinase Inhibitors Revenue by Application (2017-2028)
7.3 Europe BRAF Kinase Inhibitors Market Size by Country
7.3.1 Europe BRAF Kinase Inhibitors Sales by Country (2017-2028)
7.3.2 Europe BRAF Kinase Inhibitors Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific BRAF Kinase Inhibitors Market Size by Type
8.1.1 Asia Pacific BRAF Kinase Inhibitors Sales by Type (2017-2028)
8.1.2 Asia Pacific BRAF Kinase Inhibitors Revenue by Type (2017-2028)
8.2 Asia Pacific BRAF Kinase Inhibitors Market Size by Application
8.2.1 Asia Pacific BRAF Kinase Inhibitors Sales by Application (2017-2028)
8.2.2 Asia Pacific BRAF Kinase Inhibitors Revenue by Application (2017-2028)
8.3 Asia Pacific BRAF Kinase Inhibitors Market Size by Region
8.3.1 Asia Pacific BRAF Kinase Inhibitors Sales by Region (2017-2028)
8.3.2 Asia Pacific BRAF Kinase Inhibitors Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America BRAF Kinase Inhibitors Market Size by Type
9.1.1 Latin America BRAF Kinase Inhibitors Sales by Type (2017-2028)
9.1.2 Latin America BRAF Kinase Inhibitors Revenue by Type (2017-2028)
9.2 Latin America BRAF Kinase Inhibitors Market Size by Application
9.2.1 Latin America BRAF Kinase Inhibitors Sales by Application (2017-2028)
9.2.2 Latin America BRAF Kinase Inhibitors Revenue by Application (2017-2028)
9.3 Latin America BRAF Kinase Inhibitors Market Size by Country
9.3.1 Latin America BRAF Kinase Inhibitors Sales by Country (2017-2028)
9.3.2 Latin America BRAF Kinase Inhibitors Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa BRAF Kinase Inhibitors Market Size by Type
10.1.1 Middle East and Africa BRAF Kinase Inhibitors Sales by Type (2017-2028)
10.1.2 Middle East and Africa BRAF Kinase Inhibitors Revenue by Type (2017-2028)
10.2 Middle East and Africa BRAF Kinase Inhibitors Market Size by Application
10.2.1 Middle East and Africa BRAF Kinase Inhibitors Sales by Application (2017-2028)
10.2.2 Middle East and Africa BRAF Kinase Inhibitors Revenue by Application (2017-2028)
10.3 Middle East and Africa BRAF Kinase Inhibitors Market Size by Country
10.3.1 Middle East and Africa BRAF Kinase Inhibitors Sales by Country (2017-2028)
10.3.2 Middle East and Africa BRAF Kinase Inhibitors Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Array BioPharma Inc.
11.1.1 Array BioPharma Inc. Corporation Information
11.1.2 Array BioPharma Inc. Overview
11.1.3 Array BioPharma Inc. BRAF Kinase Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Array BioPharma Inc. BRAF Kinase Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Array BioPharma Inc. Recent Developments
11.2 Bayer AG
11.2.1 Bayer AG Corporation Information
11.2.2 Bayer AG Overview
11.2.3 Bayer AG BRAF Kinase Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Bayer AG BRAF Kinase Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bayer AG Recent Developments
11.3 F. Hoffmann-La Roche Ltd.
11.3.1 F. Hoffmann-La Roche Ltd. Corporation Information
11.3.2 F. Hoffmann-La Roche Ltd. Overview
11.3.3 F. Hoffmann-La Roche Ltd. BRAF Kinase Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 F. Hoffmann-La Roche Ltd. BRAF Kinase Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 F. Hoffmann-La Roche Ltd. Recent Developments
11.4 Novartis AG
11.4.1 Novartis AG Corporation Information
11.4.2 Novartis AG Overview
11.4.3 Novartis AG BRAF Kinase Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Novartis AG BRAF Kinase Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novartis AG Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 BRAF Kinase Inhibitors Industry Chain Analysis
12.2 BRAF Kinase Inhibitors Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 BRAF Kinase Inhibitors Production Mode & Process
12.4 BRAF Kinase Inhibitors Sales and Marketing
12.4.1 BRAF Kinase Inhibitors Sales Channels
12.4.2 BRAF Kinase Inhibitors Distributors
12.5 BRAF Kinase Inhibitors Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 BRAF Kinase Inhibitors Industry Trends
13.2 BRAF Kinase Inhibitors Market Drivers
13.3 BRAF Kinase Inhibitors Market Challenges
13.4 BRAF Kinase Inhibitors Market Restraints
14 Key Findings in The Global BRAF Kinase Inhibitors Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer